[PRNewswire] Zymo Research Pays it Forward With Their Commitment to Eradicate
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
the COVID-19 Pandemic in India
-- DNA/RNA Shield - DirectDetect™ reagent eliminates RNA extraction for rapid deployment of COVID-19 tests in affected countries
(IRVINE, Calif., Sept. 28, 2021 PRNewswire=연합뉴스) Zymo Research has donated one million COVID-19 test kits that include its new DNA/RNA Shield - DirectDetect™ [https://www.zymoresearch.com/pages/directdetect?utm_source=PRNewswire&utm_medium=Press_Release&utm_campaign=DirectDetect_India_Donation_09.28.21 ] reagent and collection devices to Mapmygenome™ based in Hyderabad, India. Mapmygenome is a molecular diagnostics company that provides personalized DNA testing, COVID-19 testing, and genetic counseling to its customers. It offers personalized health solutions to its customers based on genetic tests. They have provided COVID-19 testing throughout the pandemic at their state-of-the-art molecular testing, cGLP-compliant laboratory as well as an onsite laboratory at the Rajiv Gandhi International Airport in Hyderabad, India where they test incoming passengers for the SARS-CoV-2 virus.
DNA/RNA Shield - DirectDetect, a reagent similar to Zymo Research's established DNA/RNA Shield™, safeguards viral RNA from degradation for safe, ambient temperature collection and transportation of samples without the need for nucleic acid extraction. Removing the nucleic acid extraction step reduces the time to get PCR test results. Compared to other reagents, DNA/RNA Shield - DirectDetect does not inhibit downstream RT-PCR. The DNA/RNA Shield - DirectDetect testing kit contains the DNA/RNA Shield - DirectDetect reagent with swab collection devices.
"DNA/RNA Shield - DirectDetect enables countries seeing an increase in COVID-19 cases to perform COVID-19 testing without extraction; therefore, removing the barrier of limited extraction resources. It's our way of providing humanitarian support to people in need," said Dr. Marc Van Eden, Vice President of Business Development at Zymo Research. "We teamed up with Mapmygenome because of their ability to rapidly deploy and analyze RT-PCR testing."
"In India, where testing supplies and vaccinations are difficult to obtain, testing is imperative to diagnosing the SARS-CoV-2 virus," said Anu Acharya, Founder and CEO of Mapmygenome. She continued, "While many biotechnology and testing suppliers have tended to concentrate on their domestic testing efforts, we appreciate Zymo Research's global humanitarian effort to help eradicate COVID-19."
For more information about DNA/RNA Shield - DirectDetect and Zymo Research's donation program, visit their website [https://www.zymoresearch.com/pages/directdetect?utm_source=PRNewswire&utm_medium=Press_Release&utm_campaign=DirectDetect_India_Donation_09.28.21 ].
About Zymo Research Corp.
Zymo Research is a privately owned company that has been serving the scientific and diagnostics community with state-of-the-art molecular biology tools since 1994. The company's vision "The Beauty of Science is to Make Things Simple" is reflected in all of their products, from epigenetics to DNA/RNA purification technologies. Historically recognized as the leader in epigenetics, Zymo Research is breaking boundaries with novel solutions for sample collection, microbiomic measurements, diagnostic devices, and NGS technologies that are high quality and simple to use. Follow Zymo Research on Facebook [https://www.facebook.com/zymoresearch ], LinkedIn [https://www.linkedin.com/company/zymo-research-corp/ ], Twitter [https://twitter.com/ZymoResearch ], and Instagram [https://www.instagram.com/zymoresearch/ ].
Photo - https://mma.prnewswire.com/media/1636888/Zymo_Research_Corp_Pays_Forward.jpg
Zymo Research pays it forward by donating one million DNA/RNA Shield - DirectDetect™ test kits to Mapmygenome™ based in Hyderabad, India.
Photo - https://mma.prnewswire.com/media/1636889/Anu_and_Minister_Photo2021_09_21_at_13_56_58__1.jpg
Anu Acharya, Founder and CEO of Mapmygenome (left) and K.T. Rama Rao, Minister for Municipal Administration & Urban Development, Industries & Commerce, and Information Technology of Telangana (right).
Logo - https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg
Zymo Research Corp. Logo
Source: Zymo Research Corp.
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
출처 : PRNewswire 보도자료
- '백현동 로비' 김인섭 측근 '이재명 재판 위증' 구속영장
- 강화도 마니산 산불 야간 진화 돌입…열화상 드론 투입
- 국수본부장에 우종수 경기남부청장 내정…27일 발표
- 尹 "청춘들 생각나 나도 모르게 눈물"…서해용사 '롤콜' 소회
- 출산율 최저인데…직장인 45％ "육아휴직 자유롭게 못써" | 연합뉴스
- 전두환 손자 "28일 한국 가서 5·18 유가족에 사과"
- 양희종 은퇴식날 경사…프로농구 인삼공사, 정규리그 우승 확정(종합2보) | 연합뉴스
- 尹대통령, 내달 4일 양곡관리법 거부권 행사할 듯(종합) | 연합뉴스
- 분양권 전매제한 완화 이번주 시행…실거주의무 폐지는 아직 | 연합뉴스
- 與 "野, 꼼수탈당 반성 없이 한동훈 탄핵?…왜 이재명 탄핵않나"